1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C,
Rebelo M, Parkin DM, Forman D and Bray F: Cancer incidence
and mortality worldwide: Sources, methods and major patterns
in GLOBOCAN 2012. Int J Cancer 136: E359‑E386, 2015.
2. Oue N, Sentani K, Sakamoto N and Yasui W: Clinicopathologic
and molecular characteristics of gastric cancer showing
gastric and intestinal mucin phenotype. Cancer Sci 106:
951‑958, 2015.
3. Lauren P: The two histological main types of gastric carcinoma:
Diffuse and so‑called intestinal‑type carcinoma. An attempt at
a histo‑clinical classification. Acta Pathol Microbiol Scand 64:
31‑49, 1965.
4. Endoh Y, Sakata K, Tamura G, Ohmura K, Ajioka Y, Watanabe H
and Motoyama T: Cellular phenotypes of differentiated‑type
adenocarcinomas and precancerous lesions of the stomach are
dependent on the genetic pathways. J Pathol 191: 257‑263, 2000.
5. Ohnishi M, Tokuda M, Masaki T, Fujimura T, Tai Y, Matsui H,
Itano T, Ishida T, Takahara J and Konishi R: Changes in annexin I
and II levels during the postnatal development of rat pancreatic
islets. J Cell Sci 107: 2117‑2125, 1994.
6. Gerke V and Moss SE: Annexins: From structure to function.
Physiol Rev 82: 331‑371, 2002.
7. Lu SH, Chen YL, Shun CT, Lai JN, Peng SY, Lai PL and Hsu HC:
Expression and prognostic significance of gastric‑specific
annexin A10 in diffuse‑ and intestinal‑type gastric carcinoma.
J Gastroenterol Hepatol 26: 90‑97, 2011.
8. Lu SH, Yuan RH, Chen YL, Hsu HC and Jeng YM: Annexin
A10 is an immunohistochemical marker for adenocarcinoma
of the upper gastrointestinal tract and pancreatobiliary system.
Histopathology 63: 640‑648, 2013.
9. Kodaira H, Koma YI, Hosono M, Higashino N, Suemune K,
Nishio M, Shigeoka M and Yokozaki H: ANAX10 induction
by interaction with tumor‑associated macrophages the growth
of esophageal squamous cell carcinoma. Pathol Int 69: 135‑147,
2019.
10. Shimizu T, Kasamatsu A, Yamamoto A, Koike K, Ishige S,
Takatori H, Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H and
Uzawa K: Annexin A10 in human oral cancer: Biomarker for
tumoral growth via G1/S transition by targeting MAPK signaling
pathways. PLoS One 7: e45510, 2012.
11. Masaki T, Tokuda M, Ohnishi M, Watanabe S, Fujimura T,
Miyamoto K, Itano T, Matsui H, Arima K, Shirai M, et al:
Enhanced expression of the protein kinase substrate annexin in
human hepatocellular carcinoma. Hepatology 24: 72‑81, 1996.
12. Kim JH, Rhee YY, Kim KJ, Cho NY, Lee HS and Kang GH:
Annexin A10 expression correlates with serrated pathway
features in colorectal carcinoma with microsatellite instability.
APMIS 122: 1187‑1195, 2014.
13. Tsai JH, Lin YL, Cheng YC, Chen CC, Lin LI, Tseng LH,
Cheng ML, Liau JY and Jeng YM: Aberrant expression of
annexin A10 is closely related to gastric phenotype in serrated
pathway to colorectal carcinoma. Mod Pathol 28: 268‑278, 2015.
14. Gonzalo DH, Lai KK, Shadrach B, Goldblum JR, Bennett AE,
Downs‑Kelly E, Liu X, Henricks W, Patil DT, Carver P, et al:
Gene expression profiling of serrated polyps identifies
annexin A10 as a marker of a sessile serrated adenoma/polyp.
J Pathol 230: 420‑429, 2013.
15. Bartley AN, Thompson PA, Buckmeier JA, Kepler CY, Hsu CH,
Snyder MS, Lance P, Bhattacharyya A and Hamilton SR:
Expression of gastric pyloric mucin, MUC6, in colorectal
serrated polyps. Mod Pathol 23: 169‑176, 2010.
16. Gibson JA, Hahn HP, Shahsafaei A and Odze RD: MUC
expression in hyperplastic and serrated colonic polyps: Lack of
specificity of MUC6. Am J Surg Pathol 35: 742‑749, 2011.
17. Walsh MD, Clendenning M, Williamson E, Pearson SA, Walters RJ,
Nagler B, Packenas D, Win AK, Hopper JL, Jenkins MA, et al:
Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins
in colorectal cancers and their association with the CpG island
methylator phenotype. Mod Pathol 26: 1642‑1656, 2013.
18. Kim J, Kim MA, Jee CD, Jung EJ and Kim WH: Reduced
expression and homozygous deletion of annexin A10 in gastric
carcinoma. Int J Cancer 125: 1842‑1850, 2009.
19. Kim JK, Kim PJ, Jung KH, Noh JH, Eun JW, Bae HJ, Xie HJ,
Shan JM, Ping WY, Park WS, et al: Decreased expression of
Annexin A10 in gastric cancer and its overexpression in tumor
cell growth suppression. Oncol Rep 24: 607‑612, 2010.
20. Brooke NM, Garcia‑Fernàndez J and Holland PW: The ParaHox
gene cluster is an evolutionary sister of the Hox gene cluster.
Nature 392: 920‑922, 1998.
21. Koizumi M, Doi R, Toyoda E, Masui T, Tulachan SS,
Kawaguchi Y, Fujimoto K, Gittes GK and Imamura M: Increased
PDX‑1 expression is associated with outcome in patients with
pancreatic cancer. Surgery 134: 260‑266, 2003.
22. Ma J, Chen M, Wang J, Xia HH, Zhu S, Liang Y, Gu Q,
Qiao L, Dai Y, Zou B, et al: Pancreatic duodenal homeobox‑1
(PDX1) functions as a tumor suppressor in gastric cancer.
Carcinogenesis 29: 1327‑1333, 2008.
23. Sakamoto N, Feng Y, Stolfi C, Kurosu Y, Green M, Lin J,
Green ME, Sentani K, Yasui W, McMahon M, et al: BRAFV600E
cooperates with CDX2 inactivation to promote serrated colorectal
tumorigenesis. Elife 6: e20331, 2017.
24. Yanagihara K, Tanaka H, Takigahira M, Ino Y, Yamaguchi Y,
Toge T, Sugano K and Hirohashi S: Establishment of two cell
lines from human gastric scirrhous carcinoma that possess the
potential to metastasize spontaneously in nude mice. Cancer
Sci 95: 575‑582, 2004.
25. Yasui W, Ayhan A, Kitadai Y, Nishimura K, Yokozaki H,
Ito H and Tahara E: Increased expression of p34cdc2 and its
kinase activity in human gastric and colonic carcinomas. Int J
Cancer 53: 36‑41, 1993.
26. Sakamoto N, Naito Y, Oue N, Sentani K, Uraoka N, Oo HZ,
Yanagihara K, Aoyagi K, Sasaki H and Yasui W: MicroRNA‑148a
is downregulated in gastric cancer, targets MMP7, and indicates
tumor invasiveness and poor prognosis. Cancer Sci 105: 236‑243,
2014.
27. Yui S, Nakamura T, Sato T, Nemoto Y, Mizutani T, Zheng X,
Ichinose S, Nagaishi T, Okamoto R, Tsuchiya K, et al: Functional
engraftment of colon epithelium expanded in vitro from a single
adult Lgr5+ stem cell. Nat Med 18: 618‑623, 2012.
28. Koo BK, Sasselli V and Clevers H: Retroviral gene expression
control in primary organoid cultures. Curr Protoc Stem Cell
Biol 27: Unit 5A.6, 2013.
29. Livak KJ and Schmittgen TD: Analysis of relative gene expres‑
sion data using real‑time quantitative PCR and the 2(‑Delta Delta
C(T)) method. Methods 25: 402‑408, 2001.
30. Kim TH and Shivdasani RA: Stomach development, stem cells
and disease. Development 143: 554‑565, 2016.
31. Sato T, Vries RG, Snippert HJ, van de Wetering M, Barker N,
Stange DE, van Es JH, Abo A, Kujala P, Peters PJ and
Clevers H: Single Lgr5 stem cells build crypt‑villus structures
in vitro without a mesenchymal niche. Nature 459: 262‑265, 2009.
32. Fujii M, Shimokawa M, Date S, Takano A, Matano M, Nanki K,
Ohta Y, Toshimitsu K, Nakazato Y, Kawasaki K, et al: A
colorectal tumor organoid library demonstrates progressive loss
of niche factor requirements during tumorigenesis. Cell Stem
Cell 18: 827‑838, 2016.
33. Bartfeld S, Bayram T, van de Wetering M, Huch M, Begthel H,
Kujala P, Vries R, Peters PJ and Clevers H: In vitro expansion of
human gastric epithelial stem cells and their responses to bacte‑
rial infection. Gastroenterology 148: 126‑136.e126, 2015.
34. Cancer Genome Atlas Research Network: Comprehensive molec‑
ular characterization of gastric adenocarcinoma. Nature 513:
202‑209, 2014.
35. van de Wetering M, Francies HE, Francis JM, Bounova G, Iorio F,
Pronk A, van Houdt W, van Gorp J, Taylor‑Weiner A, Kester L, et al:
Prospective derivation of a living organoid biobank of colorectal
cancer patients. Cell 161: 933‑945, 2015.
...
論文の公開元へ
